The Filing Desk

Innoviva vs Sinovac Biotech

Innoviva INVA · Sinovac Biotech SVA · Pharmaceuticals

Innoviva reported revenue of $411 million in fiscal 2025, about the same as Sinovac Biotech's $386 million in fiscal 2025. Innoviva's revenue grew 14.7% in its latest year, and Sinovac Biotech's grew 6.8%. Innoviva had an operating margin of 39.8%, against -127.0% at Sinovac Biotech. Free cash flow was $196 million at Innoviva and −$561 million at Sinovac Biotech.

Side by side

InnovivaSinovac Biotech
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$411M$386M
Revenue growth14.7%6.8%
Revenue growth a year, last 5 years4.1%−5.4%
Gross margin74.8%67.9%
Operating margin39.8%−127.0%
Net margin65.9%−51.5%
Free cash flow$196M−$561M
Free cash flow margin47.6%−145.4%
Return on capital17.9%—
Net debt to EBITDA——
Dividends and buybacks$4M$3.5B
Change in diluted share count14.2%0.0%
Last close$18.41—
P/E at the last close9.2×—
Insider trades, last 12 months——
Piotroski F-score6 of 93 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
InnovivaSinovac Biotech
Operating margin
Percent of revenue
InnovivaSinovac Biotech
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
InnovivaSinovac Biotech

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Innoviva and Sinovac Biotech pages.